Receipt of a significant orders by a company affiliated with Selvita S.A.

The Management Board of Selvita S.A., with its registered office inKraków (the "Issuer"), hereby informs that on July 22, 2025, theIssuer's subsidiary - Selvita d.o.o. (the "Company") - received threeorders for the performance of research work (the "Orders") from one ofthe largest pharmaceutical companies based in Europe (the "Client"). Theorders constitute a continuation of the long-term cooperation, based ona framework agreement for the provision of services concluded in July2015.

Under the orders, the Company will provide continued comprehensivescientific support in the field of ADME/DMPK research (Absorption,Distribution, Metabolism, and Excretion/Pharmacokinetics, ADME/PK, drugmetabolism and pharmacokinetics), physicochemical profiling services,analytical services, and in-vivo PK (Pharmacokinetics) studies for largeand small molecules to support the client's research programs. The workunder these orders will be carried out at the laboratory in Zagreb andwill last until December 31, 2025.

The value of the received Orders amounts to EUR 2,800,000 (PLN11,908,680, converted at the average exchange rate of the National Bankof Poland as of July 22, 2025, 1 EUR = 4.2531 PLN).

Considering the value of the Orders and the strategic nature of thecontinued collaboration, the Management Board of the Issuer deems thereceived Orders to be significant for the execution of the SelvitaGroup's long-term plans aimed at building a strong position as a leadingprovider of services in the area of drug discovery and developmentsupport, as well as enhancing cooperation with large pharmaceuticalcompanies.

Disclaimer: This English language translation has been prepared solelyfor the convenience of English-speaking readers. Despite all the effortsdevoted to this translation, certain discrepancies, omissions, orapproximations may exist. In case of any differences between the Polishand the English versions, the Polish version shall prevail. SelvitaS.A., its representatives, and employees decline all responsibility inthis regard.